Dotmatics Limited, a leading provider of scientific informatics solutions and services to the Pharmaceutical and Biotechnology industries, announces that NeuroTherapeutics Pharma, Inc has licensed and deployed the Dotmatics informatics platform.
NTP’s increasing need for an informatics system, to manage their chemistry and related data, led them to assess and evaluate available solutions in the market.
“We required a database solution to manage our R&D data in an organized and accessible way. Having set a criteria that vendors needed to meet, Dotmatics came above and beyond”, says NTP.
“We are very pleased to have been selected by NTP as their informatics partner. We are looking forward to many years of collaboration and productive development with them” said Bill Bailey, Global Head of Sales and Marketing. “Their rigorous evaluation and selection process demonstrates the high quality of Browser, Vortex, Gateway, Pinpoint and Nucleus, and the excellent level of support provided by our services team” he added.
Pharma NeuroTherapeutics Pharma, Inc. (NTP) is a Biopharmaceutical company developing new therapies to treat pain, epilepsy, and other nervous system disorders. NTP is advancing compounds that act through a novel mechanism of action to create a new class of medicines with potential broad application across a range of neurological and neuropsychiatric conditions.
Dotmatics has rapidly emerged as a preferred informatics supplier to many of the top global Pharmaceutical, Biotechnology, and Academic organisations. Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, managed and shared within companies. Dotmatics has significant expertise in Cheminformatics and Bioinformatics techniques including Chemical databases, SAR analysis, data management and data visualization. A privately owned company, Dotmatics was founded in 2005 and has its head office based south of Cambridge, UK.